Cite
Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
MLA
Phan, V., et al. “Skeletal Findings in the First 12 Months Following Initiation of Glucocorticoid Therapy for Pediatric Nephrotic Syndrome.” Osteoporosis International, vol. 25, no. 2, Feb. 2014, pp. 627–37. EBSCOhost, https://doi.org/10.1007/s00198-013-2466-7.
APA
Phan, V., Blydt-Hansen, T., Feber, J., Alos, N., Arora, S., Atkinson, S., Bell, L., Clarson, C., Couch, R., Cummings, E., Filler, G., Grant, R., Grimmer, J., Hebert, D., Lentle, B., Ma, J., Matzinger, M., Midgley, J., Pinsk, M., & Rodd, C. (2014). Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome. Osteoporosis International, 25(2), 627–637. https://doi.org/10.1007/s00198-013-2466-7
Chicago
Phan, V., T. Blydt-Hansen, J. Feber, N. Alos, S. Arora, S. Atkinson, L. Bell, et al. 2014. “Skeletal Findings in the First 12 Months Following Initiation of Glucocorticoid Therapy for Pediatric Nephrotic Syndrome.” Osteoporosis International 25 (2): 627–37. doi:10.1007/s00198-013-2466-7.